XML 22 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Equity
6 Months Ended
Jun. 30, 2020
Equity  
Note 5 - Equity

Common and Preferred Stock

 

The Company is authorized to issue 10,000,000,000 shares of common stock and 1,000,000 shares of preferred A (each share convertible on one for one base for common stock, no voting rights), 10,000 shares of preferred A-2 convertible into four times the sum of all shares of common stock issued and outstanding with the same voting rights), 1,000,000 shares of preferred B (each share converted into 10 shares of common stock and has 10 votes for any election) and 1,000 shares of preferred C class (each share is not convertible and has voting rights equal to four time the sum of total common stock shares issued and outstanding plus the total number of series B, A and A-2 that are issued and outstanding.)

 

During the six months ended June 30, 2020, the Company did not issue any shares for compensation. During the six months ended June 30, 2019, the Company issued an aggregate of 775,000,000 shares of common stock for compensation of $77,500 valued at the stock price on grant date.

 

During the six months ended June 30, 2020, the Company issued 105,163,333 shares of common stock for interest conversion. During the six months ended June 30, 2019, the Company issued 2,001,133,771 shares of common stock for note or interest conversion of $172,643.

 

There were no warrants exercised during the six months ended June 30, 2020 and 2019.

 

Warrants

 

The Company accounted for the issuance of Warrants in conjunction with the issuance of convertible notes as an equity instrument and recognized the warrants under the Black-Scholes valuation model based on the Company’s market share price on the grant date.

 

The below table summarizes warrant activity during the six months ended June 30, 2020:

 

 

 

Number of

Shares

 

 

Weighted- Average Exercise Price

 

Balances as of December 31, 2019

 

 

1,436

 

 

$ 750

 

Granted

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

Forfeited

 

 

(1,410 )

 

 

-

 

Balances as of June 30, 2020

 

 

26

 

 

$ 750

 

 

The following table summarizes information relating to outstanding and exercisable warrants as of June 30, 2020:

 

Warrants Outstanding

 

 

Warrants Exercisable

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

Number

 

 

Remaining Contractual

 

 

Weighted Average

 

 

Number

 

 

Weighted Average

 

of Shares

 

 

life (in years)

 

 

Exercise Price

 

 

of Shares

 

 

Exercise Price

 

 

26

 

 

 

0.23

 

 

$ 750

 

 

 

26

 

 

$ 750

 

 

As of June 30, 2020, the aggregate intrinsic value of warrants outstanding was $0.00 based on the closing market price of $0.0005 on June 30, 2020.